We offer a range of active UK equity solutions to meet our clients’ needs. Our experienced team apply a common investment philosophy and process across our fund range, underpinned by a structured sector approach and high levels of company access. The team also incorporate an assessment of environmental, social & governance (ESG) factors, and draws on the expertise of other investment teams across the firm. Our portfolios are driven by the teams’ highest conviction stock ideas, supported by high levels of corporate engagement and rigorous risk oversight.
Our UK equity funds aim to capture the capital growth and income opportunities that abound in the UK stock market. We offer differentiated, results-orientated strategies that emphasise risk-adjusted returns.
For further information on the risks and risk profiles of our funds, please refer to the relevant KIID and Prospectus.
The value of an investment and any income from it can go down as well as up. Investors may not get back the original amount invested.
Strategies in focus
Aviva Investors UK Listed Equity Income Fund
A strategy that employs a dynamic bottom-up investment process focusing on generating long-term capital growth and a yield that is higher than the FTSE All-Share Index.
UK equity strategies
UK equities team
Chief Investment Officer, Equities and Head of UK Equities
Senior Portfolio Manager
Senior Portfolio Manager
Read more about the funds
Key Investor Information Document - Aviva Investors UK Listed Equity Unconstrained Fund - Class 2 GBP INC
Key Investor Information Document - Aviva Investors UK Listed Equity Income Fund - Class 2 GBP ACC
Key Investor Information Document - Aviva Investors UK Listed Equity Income Fund - Class 2 GBP INC
Key Investor Information Document - Aviva Investors UK Smaller Companies Fund - Class 2 GBP ACC
Explore our equities range
Our range of global equity funds is underpinned by a robust, repeatable investment process to meet clients' objectives across capital growth, income and responsible investing.
Global emerging market equities
A range of strategies that offer investors specialist exposure to a rapidly growing asset class, with portfolios targeting income and smaller companies.
Equities and COVID-19: Now is not the time to double-down on uncertainty
21 May 2020
As the effects of COVID-19 continue to rip through societies and economies, Trevor Green explains why adding uncertainty on top of uncertainty is never a good investment strategy. He outlines three critical, but simple, rules for navigating the current equity market.
COVID-19: The impact on global equities
28 Apr 2020
As the coronavirus pandemic wreaks havoc on global economies, Giles Parkinson assesses the impact across equity markets and the longer-term implications for investors.
Size matters: Will COVID-19 lead to a concentration of corporate power?
22 Apr 2020
The fallout from the coronavirus pandemic could see large firms cement their dominance over weaker rivals. We examine the implications for investors.
Are investors too complacent about the coronavirus?
21 Feb 2020
In the latest of our editorial series, Link, AIQ brings members of Aviva Investors’ investment strategy, equity and debt teams together to discuss the prospects for financial markets and the world economy in the face of the coronavirus epidemic.
Cwtch: Has capitalism gone cuddly?
18 Feb 2020
In the first of a new editorial series, Link, AIQ brings together people from across Aviva Investors to debate topical themes. Mirza Baig and Stephanie Niven consider whether CEO claims about running businesses for multiple stakeholders rather than shareholders alone is a grand idea or just plain grandstanding.
Multi-asset allocation views: Why the bull run in global equities could continue
12 Feb 2020
Sunil Krishnan discusses the conditions for a continued rise in global equities, the potential of Japanese and US equities to outperform from a regional perspective, and some attractive features of emerging markets – particularly Brazil – which may have been overlooked.
Dealing with climate change: A mixture of mitigation and adaptation
4 Dec 2019
The asset management industry has a key role to play in the face of the climate emergency facing humanity. We spoke to Emma Haziza, hydrologist, PhD Mines ParisTech, Founder and President of Mayane, and Rick Stathers, Climate Specialist at Aviva Investors to find out how asset managers can support companies in their climate transition efforts.
In a complex market, investors need to connect information signals more effectively
19 Nov 2019
A growing body of research suggests equity investors are poor at recognising the connections and interrelationships between companies. A fresh approach is needed, argues Mikhail Zverev, head of global equities at Aviva Investors.
5G: Anatomy of an equity investment idea
11 Nov 2019
The evolution of wireless technology has fuelled a host of new mobile applications and helped propel companies such as Netflix. 5G, its next iteration, promises speeds up to 20 times faster than the current 4G. But to think only in terms of speed severely underestimates 5G’s potential to fundamentally transform the business landscape – though not without tremendous risk.
Back to the future: Dr Eric Topol on AI in healthcare
3 Oct 2019
In the final article in our series on healthcare, we speak to the renowned cardiologist and author Eric Topol about his new book, Deep Medicine.
Substance over style?
30 Sep 2019
Why an agnostic approach beats equity style biases.
Big Tech bets on healthcare
25 Sep 2019
In the third of a four-part series on healthcare, we focus on technology. New tech innovations promise to deliver better treatments and cost efficiencies – but concerns over data protection and flawed AI persist.
Biotech disrupters shake up the drug discovery business
18 Sep 2019
In the second of a four-part series on healthcare, we look at how competition between Big Pharma, Chinese biotech and Silicon Valley is transforming the landscape of drug discovery.
Investors must hold bad bosses to account
16 Sep 2019
Institutional shareholders need to be as agile and active as private equity in dealing with failures of leadership.
Medicine, politics and investing: Tensions abound
12 Sep 2019
In the first of a four-part series on global healthcare, we look at why the sector is likely to take centre stage in the 2020 US elections and what this means for investors.
As China soars, emerging market investors need a rethink
21 Aug 2019
With China set to dominate EM equity indices over the coming decades, investors need to adjust their approach to the asset class, argues Alistair Way.